| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |